Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.

Source:http://linkedlifedata.com/resource/pubmed/id/15359575

Download in:

View as

General Info

PMID
15359575